TNFRSF13C and B-cell non-Hodgkin lymphoma: reported the initial results of the NCT05370430 study, evaluating the safety and efficacy of autologous BAFFR-targeted CAR-T cells in three patients with B-cell lymphoma (2 patients with mantle cell lymphoma, 1 patient with T-cell/histiocyte-rich B-cell lymphoma).